Senseonics Holdings (SENS): Management Meetings Confirm Hyper Growth Sales Trajectory - Leerink
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Leerink Partners analyst, Danielle Antalffy, reiterated her Outperform rating on shares of Senseonics Holdings (NYSE: SENS) and raised her price target to $6.00 from $4.50 after hosting a week of investor meetings with President & CEO Tim Goodnow and CFO Don Elsey.
The analyst stated: "These meetings supported our bullish outlook on SENS and the Eversense implantable CGM (continuous glucose monitor) EU launch now underway and U.S. launch in 2018 and beyond. And they reinforced our view that SENS has a sustainable hyper-growth sales trajectory longer-term, with a number of key milestones in the near-term to continue to support the shares".
Shares of Senseonics Holdings closed at $4.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades NetApp (NTAP) to Underperform
- Illumina (ILMN) Lower as Morgan Stanley Cuts Numbers, Sees Slow Growth Persisting
- BWS Financial Cuts Price Target on Sigma Designs (SIGM) to $5.00
Create E-mail Alert Related CategoriesAnalyst Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!